| 103178 |
ONCOIMMUNOLOGY |
Boosting antibody-dependant cellular cytotoxicity against tumor cells with a CD137 stimulatory antibody |
2012-09-01 |
10.4161/onci.19974 |
Houot Roch, Kohrt Holbrook, Levy Ron |
| 103177 |
ORAL DISEASES |
Plenary Abstracts |
2012-09-01 |
10.1111/j.1601-0825.2012.12004.x |
|
| 103176 |
ORAL DISEASES |
Original Research Basic Science |
2012-09-01 |
10.1111/j.1601-0825.2012.12005_1.x |
|
| 103175 |
ONCOIMMUNOLOGY |
TAMable tumor-associated macrophages in response to innate RNA sensing |
2012-09-01 |
10.4161/onci.19894 |
Seya Tsukasa, Shime Hiroaki, Matsumoto Misako |
| 103174 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Kinase inhibitors: a new class of antirheumatic drugs |
2012-09-01 |
10.2147/dddt.s25426 |
Kyttaris Vasileios |
| 103173 |
ONCOTARGETS AND THERAPY |
Carfilzomib: a novel treatment in relapsed and refractory multiple myeloma |
2012-09-01 |
10.2147/ott.s28911 |
Schots Rik, Fostier, De Becker |
| 103172 |
ONCOIMMUNOLOGY |
The role of tumor expression of CD200 in tumor formation, metastasis and susceptibility to T lymphocyte adoptive transfer therapy |
2012-09-01 |
10.4161/onci.20034 |
Talebian Fatemeh, Bai Xue-Feng |
| 103171 |
ONCOIMMUNOLOGY |
Understanding key assay parameters that affect measurements of trastuzumab-mediated ADCC against Her2 positive breast cancer cells |
2012-09-01 |
10.4161/onci.20447 |
Kute Timothy, Stehle, Jr. John R., Ornelles David, Walker Natalie, Delbono Osvaldo, Vaughn James P. |
| 103170 |
ONCOIMMUNOLOGY |
Combined targeted therapy and immunotherapy in the treatment of advanced melanoma |
2012-09-01 |
10.4161/onci.19865 |
Wilmott James S., Scolyer Richard A., Long Georgina V., Hersey Peter |
| 103169 |
ONCOIMMUNOLOGY |
AAV2/IL-12 gene delivery into dendritic cells (DC) enhances CTL stimulation above other IL-12 applications : Evidence for IL-12 intracrine activity in DC |
2012-09-01 |
10.4161/onci.20504 |
You Chang-Xuan, Shi Min, Liu Yong, Cao Maohua, Luo Rongcheng, Hermonat Paul L. |
